scPharmaceuticals Secures $10 Million Unsecured Loan from MannKind Corporation Amid Pending Merger

scPharmaceuticals Inc. Secures $10 Million Loan from MannKind Corporation Burlington, MA - September 24, 2025 - scPharmaceuticals Inc. has entered into a new financing agreement with MannKind Corporation, securing a $10 million unsecured loan. The arrangement was formalized on September 23, 2025, with scPharmaceuticals issuing a promissory note to MannKind in exchange for the funds. The note carries an interest rate tied to the company’s existing credit agreement, with a margin ranging between 4.75% and 5.00%. The new loan comes as part of a broader merger transaction announced in August, under which MannKind plans to acquire scPharmaceuticals through a tender offer. The loan can be prepaid in full at any time before maturity, and includes customary financial covenants and restrictions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. scPharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-214262), on September 24, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here